[The status of imaging methods for the treatment of patients with Parkinson's syndrome]

J Schwarz; S Gratz; U Hahn; H Förstl; M Jarnig

doi:10.1055/s-2008-1075679

[The status of imaging methods for the treatment of patients with Parkinson's syndrome]

Dtsch Med Wochenschr. 2008 May:133 Suppl 1:S8-10. doi: 10.1055/s-2008-1075679.

[Article in German]

Authors

J Schwarz¹, S Gratz, U Hahn, H Förstl, M Jarnig

Affiliation

¹ Klinik und Poliklinik für Neurologie, Universität Leipzig. johannes@caltech.edu

PMID: 18437640
DOI: 10.1055/s-2008-1075679

Abstract

The accuracy of the diagnosis of Parkinson's disease early in the course of the disease remains a clinical challenge. Imaging of dopamine transporters with DatSCAN and SPEC tomography contributes to identifying patients without nigral degeneration and thus helps preventing unnecessary and potentially harmful treatments. The cost of these imaging procedures needs to be set against the cost of unnecessary medication.

Publication types

English Abstract
Review

MeSH terms

Cost-Benefit Analysis
Dopamine Agents / economics
Dopamine Agents / therapeutic use
Dopamine Plasma Membrane Transport Proteins / analysis
Dopamine Plasma Membrane Transport Proteins / metabolism
Humans
Parkinson Disease / diagnosis*
Parkinson Disease / physiopathology
Parkinson Disease / therapy*
Positron-Emission Tomography* / economics
Sensitivity and Specificity
Substantia Nigra / pathology
Tomography, Emission-Computed, Single-Photon* / economics

Substances

Dopamine Agents
Dopamine Plasma Membrane Transport Proteins